Stephen Dilly
Chief Executive Officer at CODEXIS, INC.
Net worth: 2 M $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| H. Parker | F | 68 | 10 years | |
| Byron L. Dorgan | M | 81 | 13 years | |
| Alexander Macrae | M | 61 | 8 years | |
| Sriram Ryali | M | 43 | 5 years | |
| Margaret Fitzgerald | F | 53 | 2 years | |
| Thomas A. Shea | M | 64 |
ImmunoMolecular Therapeutics, Inc.
 ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology ImmunoMolecular Therapeutics LLC develops and manufactures immuno-therapeutic drugs for autoimmune diseases. The firm offers oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. The company was founded by Steve Orndorff, Aaron Michels, and Peter Gottlieb in 2015 and is headquartered in Broomfield, CO. | - |
| Prathyusha Durabaibu | F | 46 | 5 years | |
| Peter Gottlieb | M | - |
ImmunoMolecular Therapeutics, Inc.
ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology ImmunoMolecular Therapeutics LLC develops and manufactures immuno-therapeutic drugs for autoimmune diseases. The firm offers oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. The company was founded by Steve Orndorff, Aaron Michels, and Peter Gottlieb in 2015 and is headquartered in Broomfield, CO. | 9 years |
| David Smith | M | 64 | 8 years | |
| John Markels | M | 58 | 4 years | |
| Robert Sato | M | - | 17 years | |
| Kevin Norrett | M | 51 | 4 years | |
| Esther Martinborough | M | 58 | 3 years | |
| Lauren Rose Musto | F | - | 3 years | |
| Louise Wilkie | F | - | 4 years | |
| Sharief Taraman | M | - |
Cognoa, Inc.
 Cognoa, Inc. Medical/Nursing ServicesHealth Services Cognoa, Inc. offers a mobile application and proprietary algorithm to enable early detection of autism. The firm is a consumer healthcare company that?s changing how parents assess and support their child?s development. The company was founded by Dennis Wall and Brent Vaughan and is headquartered in Palo Alto, CA. | 7 years |
| Rahul Singhvi | M | 59 | 2 years | |
| Aaron Michels | M | - |
ImmunoMolecular Therapeutics, Inc.
ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology ImmunoMolecular Therapeutics LLC develops and manufactures immuno-therapeutic drugs for autoimmune diseases. The firm offers oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. The company was founded by Steve Orndorff, Aaron Michels, and Peter Gottlieb in 2015 and is headquartered in Broomfield, CO. | 9 years |
| Tyler Martin | M | - |
Adjuvance Technologies, Inc.
 Adjuvance Technologies, Inc. Pharmaceuticals: GenericHealth Technology Adjuvance Technologies, Inc.is a biopharmaceutical company. The company was founded by Jeffrey Gardner and is headquartered in Lincoln, NE. | - |
| Robert Carey | M | 65 | 8 years | |
| James Meyers | M | 58 | 5 years | |
| Dennis P. Wolf | M | 71 | 17 years | |
| Kenneth Hillan | M | 63 | 4 years | |
| Isaac Cheng | M | 49 |
Adjuvance Technologies, Inc.
Adjuvance Technologies, Inc. Pharmaceuticals: GenericHealth Technology Adjuvance Technologies, Inc.is a biopharmaceutical company. The company was founded by Jeffrey Gardner and is headquartered in Lincoln, NE.
Cognoa, Inc.
Cognoa, Inc. Medical/Nursing ServicesHealth Services Cognoa, Inc. offers a mobile application and proprietary algorithm to enable early detection of autism. The firm is a consumer healthcare company that?s changing how parents assess and support their child?s development. The company was founded by Dennis Wall and Brent Vaughan and is headquartered in Palo Alto, CA. | - |
| Alison Moore | M | 57 | 4 years | |
| Karen Smith | M | 56 | 6 years | |
| Jennifer Aaker | M | 57 | 4 years | |
| Gregory Davis | M | - | 4 years | |
| Ken Kelley | M | - |
Adjuvance Technologies, Inc.
Adjuvance Technologies, Inc. Pharmaceuticals: GenericHealth Technology Adjuvance Technologies, Inc.is a biopharmaceutical company. The company was founded by Jeffrey Gardner and is headquartered in Lincoln, NE. | - |
| Stefan Lutz | M | - | 4 years | |
| Nandan Padukone | M | - |
ImmunoMolecular Therapeutics, Inc.
ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology ImmunoMolecular Therapeutics LLC develops and manufactures immuno-therapeutic drugs for autoimmune diseases. The firm offers oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. The company was founded by Steve Orndorff, Aaron Michels, and Peter Gottlieb in 2015 and is headquartered in Broomfield, CO. | - |
| Ed Orr | M | - |
ImmunoMolecular Therapeutics, Inc.
ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology ImmunoMolecular Therapeutics LLC develops and manufactures immuno-therapeutic drugs for autoimmune diseases. The firm offers oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. The company was founded by Steve Orndorff, Aaron Michels, and Peter Gottlieb in 2015 and is headquartered in Broomfield, CO. | - |
| Karen Frechou-Armijo | F | - | 3 years | |
| Nathalie Dubois Stringfellow | M | - | 5 years | |
| Laurie Heilmann | F | 68 | 5 years | |
| Margaret Liu | M | 66 |
Adjuvance Technologies, Inc.
Adjuvance Technologies, Inc. Pharmaceuticals: GenericHealth Technology Adjuvance Technologies, Inc.is a biopharmaceutical company. The company was founded by Jeffrey Gardner and is headquartered in Lincoln, NE. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Mary Christina Thomson | F | 53 |
APT Pharmaceuticals, Inc.
 APT Pharmaceuticals, Inc. BiotechnologyHealth Technology APT Pharmaceuticals, Inc. operated as a drug development company. The company was founded on December 15, 1999 and was headquartered in Burlingame, CA.
Avigen, Inc.
 Avigen, Inc. Medical SpecialtiesHealth Technology Avigen, Inc. produces and sells drugs, animal health products, and chemicals. The firm also develops and commercializes small molecules of therapeutics and biologics for use in the treatment of serious neurological and neuromuscular disorders. The company was founded in 1992 and is headquartered in La Jolla, CA. | 12 years |
| Edward O. Lanphier | M | 67 | 22 years | |
| Gary Loeb | M | 54 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 14 years |
| Kathy Yi | F | 52 | 2 years | |
| John Nicols | M | 60 | 11 years | |
| Jayson Dallas | M | 56 | 2 years | |
| Bernard J. Kelley | M | 82 | 17 years | |
| Robert A. Swanson | M | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 23 years |
| Bryan L. Walser | M | 57 | 4 years | |
| William Ringo | M | 78 | 8 years | |
| Robert E. Pelzer | M | 70 | 7 years | |
| Ian Clark | M | 62 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 13 years |
| Justin T. Huang | M | - | - | |
| Heather Erickson | F | - | 8 years | |
| Barbara Klencke | M | 66 | 7 years | |
| Sona Saira Ramasastry | F | 48 | 10 years | |
| Kevin Thomas Ryan | M | - | - | |
| Christy Oliger | F | 54 | 1 years | |
| Georgia Erbez | F | 57 | 1 years | |
| James Smith | M | 54 | 8 years | |
| Diane Gardiner | F | - | - | |
| Joseph Suttner | M | - | - | |
| Aron Feingold | M | - | 4 years | |
| R. Ramelmeier | M | 62 | 5 years | |
| Emma McCann | F | - | 8 years | |
| Karl A. Schoene | M | - | 3 years | |
| Chi Keung Wong | M | 65 |
University of London
| 7 years |
| Christopher Murove | M | - |
University of London
| 4 years |
| Aloysius Kow | M | 78 |
University of London
| 3 years |
| Jason Fontenot | M | 54 | 5 years | |
| Michael Holmes | M | - | 17 years | |
| Mark McClung | M | 61 | 4 years | |
| Leslie Mesones | F | - | - | |
| Ngai Man Ng | M | 62 |
University of London
| 4 years |
| Grégory Behar | M | 55 | 4 years | |
| McDavid Stilwell | M | 53 | - | |
| Stacey Seltzer | F | 47 | 5 years | |
| Thomas Wiggans | M | 72 | 4 years | |
| Jeffrey Cooper | M | 68 | 6 years | |
| Patrick Yang | M | 75 | 9 years | |
| Craig Collard | M | 58 | 2 years | |
| Andrew Allen | M | 57 | 5 years | |
| Mohammad A. El-Kalay | M | 67 | - | |
| Heather Turner | F | 51 | 1 years | |
| Dennis J. Henner | M | 72 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 23 years |
| Tom Baruch | M | 85 | 18 years | |
| Mark McDade | M | 69 | 6 years | |
| Henry Ward Wolff | M | 75 | 10 years | |
| Kathryn Falberg | F | 63 | 5 years | |
| Paul Cleveland | M | 67 | 8 years | |
| Edward Rebar | M | 56 | 22 years | |
| David Nagler | M | 71 |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | 7 years |
| Steven Mento | M | 72 | 14 years | |
| Joseph Zakrzewski | M | 60 | 5 years | |
| Harren Jhoti | M | 61 |
University of London
| 8 years |
| Gaurav Aggarwal | M | 51 | 3 years | |
| Ross Taylor | M | 60 | 4 years | |
| Mona Ashiya | M | 55 | 3 years | |
| Douglas T. Sheehy | M | 57 | 4 years | |
| Mark Iwicki | M | 57 | 5 years | |
| William D. Turner | M | 58 | 6 years | |
| Andrew Sinclair | M | 52 | 3 years | |
| Hussam bin Saud Al-Saud | M | 64 |
University of London
| 4 years |
| Penny Dash | M | - |
University of London
| 6 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 93 | 93.00% |
| United Kingdom | 7 | 7.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Stephen Dilly
- Personal Network
